U.S. Luxury Stock News

Danaher (DHR) has just put fresh numbers on the table, with Q3 FY 2025 revenue of US$6.1 billion, basic EPS of US$1.28 and net income of US$908 million setting the tone for its latest update. The company has seen quarterly revenue move from US$5.7 billion in Q2 2024 to US$6.1 billion in Q3 2025. Over the same reported periods, basic EPS has ranged between about US$0.77 and US$1.50 as net income moved between US$555 million and US$1.09 billion. All of that now feeds into trailing twelve month...

If you are wondering whether Phibro Animal Health's current share price still offers value, this article walks through what the numbers are really saying about the stock. The share price closed at US$38.80, with returns of a 7.5% decline over the last 7 days, 2.8% over 30 days, 4.0% year to date, 80.0% over 1 year and 164.4% over 3 years, plus 101.2% over 5 years. Recent coverage has focused on Phibro Animal Health as part of wider discussions around animal health and pharmaceutical names,...

East West Bancorp, Inc. reported stronger fourth-quarter and full-year 2025 results, with higher net interest income of US$657.82 million and quarterly net income of US$356.27 million, alongside materially improved earnings per share versus the prior year. Alongside these results, the company sharply lifted its quarterly common dividend to US$0.80 per share and completed a multi-year buyback program that retired 7.38% of its shares, underscoring management’s willingness to return capital to...

In recent weeks, Chord Energy has faced mixed analyst sentiment, with Citi downgrading the stock while other firms maintained more favorable ratings amid sector-wide macro concerns. At the same time, Chord Energy moved to expand its Williston Basin footprint through a US$550 million purchase of Exxon Mobil’s XTO Energy assets, signaling a material shift in its asset base and cash flow profile. We’ll now examine how this XTO Energy asset acquisition shapes Chord Energy’s investment narrative...

As the U.S. stock market experiences fluctuations driven by mixed corporate earnings and geopolitical uncertainties, investors are increasingly attentive to undervalued opportunities amidst the volatility. In such a climate, identifying stocks that may be trading below their estimated value can offer potential for growth, provided they exhibit strong fundamentals and resilience in challenging conditions.

As the U.S. stock market faces turbulence with major indices like the Dow Jones and S&P 500 experiencing declines, investors are keenly observing companies that exhibit resilience and potential for growth. In such a volatile environment, stocks of growth companies with high insider ownership often stand out as they suggest strong internal confidence in the business's future prospects.

As the U.S. market navigates a landscape marked by fluctuating tech stocks and record highs in precious metals, investors are increasingly looking beyond the well-trodden paths of major indices to uncover potential opportunities in lesser-known small-cap stocks. In this environment, identifying undiscovered gems requires a keen eye for companies with robust fundamentals that can withstand broader market volatility and capitalize on niche growth opportunities.

As the U.S. market faces fluctuations with major indices like the Dow Jones and S&P 500 experiencing declines, investors are increasingly seeking alternative opportunities to diversify their portfolios. Penny stocks, a term that may seem outdated, continue to hold potential for those willing to explore smaller or newer companies that can offer growth at lower price points. With strong balance sheets and solid fundamentals, these stocks can present hidden gems in today's market landscape,...

As the U.S. stock market navigates through a challenging period marked by declining tech shares and fluctuating precious metal prices, investors are increasingly seeking stability amid volatility. In such an environment, dividend stocks can offer a reliable income stream, providing both potential for growth and regular returns that may help cushion against market downturns.

Elevance Health (ELV) closed out FY 2025 with Q4 revenue of US$49.7b and basic EPS of US$2.47, alongside net income of US$547m. Over the past six quarters, the company has seen quarterly revenue move from US$45.1b in Q3 2024 to a range between US$48.9b and US$50.7b through 2025, while quarterly EPS shifted from US$4.38 to US$9.64 and then to US$2.47. This sets up an earnings print where margin resilience is front of mind for investors. See our full analysis for Elevance Health. With the...

Curious whether Broadridge Financial Solutions at around US$204.89 is offering fair value or a potential bargain right now? This article walks through the numbers in a clear way so you can judge for yourself. The stock has seen mixed returns, with a 0.9% decline over the last 7 days, a 9.9% decline over the last 30 days and a 7.1% decline year to date. The 3 year and 5 year returns sit at 40.4% and 54.1% respectively, and the 1 year return is a decline of 11.6%. Recent coverage has focused...

First Busey (BUSE) has put a fuller year of numbers on the table for FY 2025, with fourth quarter revenue of US$197.8 million and EPS of US$0.63, rounding out trailing twelve month revenue of US$666.8 million and EPS of US$1.49. The company has seen revenue move from US$453.7 million and EPS of US$2.01 on a trailing basis in late 2024 to US$666.8 million and EPS of US$1.49 by the end of 2025. This is setting up a results season where investors are weighing those headline figures against a...

If you are wondering whether Icahn Enterprises at a last close of US$7.74 offers genuine value or just headline risk, you are not alone. This article is built to help you weigh that up clearly. The stock has been mixed recently, with a 6.0% return over 30 days and a 3.5% return year to date, set against a 2.4% decline over 1 year and much steeper 3 year and 5 year returns of 73.1% and 67.3% declines. These moves sit in the shadow of earlier scrutiny of Icahn Enterprises' structure and short...

Houlihan Lokey (NYSE:HLI) has expanded its European footprint with the hire of Mark Ward as Managing Director to lead IT Services coverage. The firm has also completed acquisitions in European real estate and corporate finance, adding sector depth and local capabilities. These moves reflect an active push to grow both organically and through acquisitions in key European markets. At a share price of $180.53, Houlihan Lokey has delivered a 3 year return of 94.8% and a 5 year return of 199.2%...

What Recent Performance Says About PotlatchDeltic PotlatchDeltic (PCH) has drawn investor attention after a mix of short term weakness and modest recent gains, with the share price down over the past week but up over the past month and past 3 months. See our latest analysis for PotlatchDeltic. That mix of near term weakness and recent gains fits a broader pattern, with the 30 day share price return of 3.78% and year to date share price return of 4.31% sitting against a 1 year total...

National Fuel Gas (NYSE:NFG) disclosed a significant increase in CEO compensation in a recent SEC filing. The company also announced new government contract awards, expanding its role as an energy supplier to public sector customers. These developments update investors on executive pay structures and newly secured business commitments. National Fuel Gas, traded as NYSE:NFG, operates across natural gas exploration, production, gathering, and utility services. For you as a shareholder or...

Manhattan Associates (MANH) has wrapped up FY 2025 with fourth quarter revenue of US$270.4 million and basic EPS of US$0.87, alongside net income excluding extra items of US$52.0 million. Trailing 12 month revenue came in at about US$1.1 billion with basic EPS of US$3.64. Over recent quarters, the company has seen revenue range from US$262.8 million to US$275.8 million and quarterly basic EPS move between US$0.86 and US$0.97, set against trailing 12 month EPS that has stayed around the mid...

Kinder Morgan, Inc. ( NYSE:KMI ) will pay a dividend of $0.2925 on the 17th of February. This payment means that the...

If you are wondering whether Artivion at around US$41.29 is a fair price or starting to look stretched, you are not alone. This article will focus squarely on what the current share price could mean for value minded investors. The stock has seen a 6.8% decline over the last 7 days and a 10.9% decline over the last 30 days, yet it is still up 32.3% over the past year and has a very large 3 year return alongside a 70.4% return over 5 years. Recent price moves sit against a backdrop of...

If you are wondering whether BWX Technologies at around US$216.30 is priced for perfection or still offers value, you are not alone. The share price has moved by 3.2% over the last 7 days, 23.3% over the past 30 days, 18.9% year to date and 94.4% over the past year, with a very large 5 year return that is well over 5x. Recent coverage around BWX Technologies has focused on its role in nuclear and defense related projects, as investors watch how these areas shape future contract pipelines and...

Eva Live, Inc.'s ( NASDAQ:GOAI ) price-to-sales (or "P/S") ratio of 15.3x may look like a poor investment opportunity...

SkyWest, Inc.'s ( NASDAQ:SKYW ) price-to-earnings (or "P/E") ratio of 9x might make it look like a strong buy right now...

Integra LifeSciences Holdings Corporation ( NASDAQ:IART ), is not the largest company out there, but it saw significant...

Wondering if VEON at US$54.07 is offering value or asking too much? This article walks through what the current price might be implying about the company. The stock has been relatively steady over the last week with a 0.1% decline, while the 1 year return of 19.9% and 3 year return of 260.5% sit alongside a 30 day return of 3.0% and year to date return of 2.6%. Recent news coverage has focused on VEON's position as a telecom operator listed on the Nasdaq and on how investors are interpreting...